We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SDHC:NYSESmith Douglas Homes Corp. Analysis

Data as of 2026-05-26 - not real-time

$11.99

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Smith Douglas Homes (SDHC) is trading at $11.99, well below its DCF fair value of $35.06, indicating a substantial undervaluation despite a bearish technical backdrop. The 20‑day SMA (12.38) sits above the current price, while the 200‑day SMA (16.85) is markedly higher, and the MACD histogram remains negative, signaling short‑term downside pressure. However, the RSI of 44 suggests the stock is not yet oversold, and price remains above the identified support at $10.72, offering a modest cushion.
Fundamentally, the company’s PE of 12.6 is far below the industry average of 32.8, and its price‑to‑book of 1.26 aligns with a value‑oriented profile. Revenue is contracting (-8.1%) and margins are thin, yet free cash flow of $25.7 M and a modest ROE of 12.8% provide some operational resilience. The balance sheet shows a high debt‑to‑equity ratio of 16.1, which, combined with a beta of 1.5 and 30‑day volatility of 53.7%, underscores elevated risk. The market sentiment index reads “Extreme Greed,” hinting at potential speculative buying pressure that could accelerate price movement toward the upside target.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and price below short‑term SMA
  • Proximity to technical support at $10.72
  • Decreasing volume indicating waning buying interest

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Low PE relative to industry but negative revenue growth
  • High debt‑to‑equity ratio limiting financial flexibility

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggests >200% upside potential
  • Value‑oriented metrics (low PE, reasonable P/B) and strong brand ranking
  • Long‑run recovery prospects in entry‑level housing demand

Key Metrics & Analysis

Financial Health

Revenue Growth-8.10%
Profit Margin0.90%
P/E Ratio12.6
ROE12.75%
ROA6.37%
Debt/Equity16.15
P/B Ratio1.3
Op. Cash Flow$3.9M
Free Cash Flow$25.7M
Industry P/E32.8

Technical Analysis

TrendBearish
RSI44.1
Support$10.72
Resistance$14.48
MA 20$12.38
MA 50$13.01
MA 200$16.85
MACDBearish
VolumeDecreasing
Fear & Greed Index91.13

Valuation

Fair Value$35.06
Target Price$13.13
Upside/Downside9.47%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.54
Volatility53.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.